Health Affairs, 25, no. 2 (2006): 325-336 doi: 10.1377/hlthaff.25.2.325 © 2006 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Figures Only Full Text (HTML) Reprint (PDF) Online Appendices Media/Policy Briefing Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Laxminarayan, R. Articles by Smith, D. L. Search for Related Content PubMed PubMed Citation Articles by Laxminarayan, R. Articles by Smith, D. L. Related Collections Health Promotion/Disease Prevention Health Reform International Issues Legal/Regulatory Issues Business Of Health Pharmaceuticals Public Health Research And Technology Health Spending Consumer Issues Vaccines

Drugs/Vaccines

Will A Global Subsidy Of New Antimalarials Delay The Emergence Of Resistance And Save Lives?

Artemisinin-based combination treatments (ACTs) are seen as an important tool in the global effort to roll back malaria. With parasite resistance to chloroquine increasing rapidly in many parts of the world, there is greater recognition of the need for a globally coordinated strategy to ensure that artemisinins are not used as monotherapy, which has the potential to cut short their useful therapeutic life. We find that even a partial subsidy could delay the emergence of resistance and that a delay in implementing a subsidy for ACTs could facilitate the emergence of resistance and lower the economic value of ACTs.

                      What's this?

This article has been cited by other articles:

				R. Laxminarayan and H. Gelband A Global Subsidy: Key To Affordable Drugs For Malaria? Health Aff., July 1, 2009; 28(4): 949 - 961. [Abstract] [Full Text] [PDF]

				A. Bosman and K. N. Mendis A Major Transition in Malaria Treatment: The Adoption and Deployment of Artemisinin-Based Combination Therapies Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 193 - 197. [Abstract] [Full Text] [PDF]

				H. Gelband and A. Seiter A Global Subsidy for Antimalarial Drugs Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 219 - 221. [Abstract] [Full Text] [PDF]